Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43

BACKGROUND: Two commercially available TDP43 antibodies (phosphorylated or pTDP43, non-phosphorylated or iTDP43) are currently in use for the neuropathological classification of FTLD-TDP cases into pathological subtypes. To date, no studies have performed direct comparisons between these TDP43 antib...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tan, Rachel H, Shepherd, Claire E, Kril, Jillian J, McCann, Heather, McGeachie, Andrew, McGinley, Ciara, Affleck, Andrew, Halliday, Glenda M
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2013
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4046675/ https://ncbi.nlm.nih.gov/pubmed/24252630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-5960-1-33
Tags:	Add Tag No Tags, Be the first to tag this record!

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43

Similar Items